Literature DB >> 815534

Cross-reactivity of lytic antibodies against blood forms of Trypanosoma cruzi.

F Kierszenbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 815534

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


× No keyword cloud information.
  10 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Induction of capping in blood-stage trypomastigotes of Trypanosoma cruzi by human anti-Trypanosoma cruzi antibodies.

Authors:  G A Schmuñis; A Szarfman; T Langembach; W de Souza
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

3.  Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis.

Authors:  F Kierszenbaum; M A Ramirez
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi.

Authors:  N Yoshida
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

5.  Trypanosoma musculi infections in normocomplementemic, C5-deficient, and C3-depleted mice.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

6.  Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection.

Authors:  F Kierszenbaum; M M Pienkowski
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Complement in experimental Trypanosoma lewisi infection of rats.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  A radiometric assay for diagnosing lytic antibodies in Trypanosoma cruzi infection.

Authors:  R L Cardoni; M E Rottenberg; E L Segura
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

9.  Mechanisms of resistance against experimental Trypanosoma cruzi infection. Requirements for cellular destruction of circulating forms of T. cruzi in human and murine in vitro systems.

Authors:  F Kierszenbaum; M M Hayes
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

10.  Experimental Chagas' disease in complement-deficient mice and guinea pigs.

Authors:  A P Dalmasso; J A Jarvinen
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.